Statistics

Total Visits

	Views
Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months	57

File Visits

	Downloads
Casado et al. - 2015 - Switching to second‐generation tyrosine kinase inhibitor improves the response and outcome of frontl.pdf	2

Select a period of time:

Number of views in the range

	Views
Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months	38

Number of downloads in the range

	Downloads
Casado et al. - 2015 - Switching to second‐generation tyrosine kinase inhibitor improves the response and outcome of frontl.pdf	2

Views

	Views
March 2025	15
April 2025	2
May 2025	2
June 2025	2
July 2025	7
August 2025	6
September 2025	4

untranslated

untranslated

Number of downloads in the period of time

Downloads
March 2025

0
April 2025

0
May 2025

0
June 2025

0
July 2025

0
August 2025

1
September 2025

1

untranslated

untranslated

Top country views

	Views
Singapore	16
Brazil	8
United States	3
Argentina	1
Germany	1
Spain	1
South Africa	1

Top countries by downloads

	Downloads
United States	1

Top cities views

	Views
Barbacena	1
Council Bluffs	1
Dallas	1
Fortaleza	1
Lomas de Zamora	1
Maringá	1
Munich	1
Pindamonhangaba	1
Riachão das Neves	1
Rolândia	1

Top cities by downloads

	Downloads